STADA Arzneimittel AG is a publicly traded German company listed in the M-DAX of the Frankfurt Stock Exchange, with 2017 global sales of €2.31 billion. STADA is a truly international company with a focus on the diverse healthcare markets, including speciality pharmaceuticals, generic medicines and OTC products.

STADA enables Britannia’s in-house team of experts to run our research and development programmes, as well as providing the financial investment needed to support our expansion strategy.

STADA's mission

For more than 120 years STADA is taking care of a great good: your health. The care of health and well-being of people is the centre of STADA’s trade. The company’s Philosophy and mission statement is based on it. ALL THE BEST verbalizes it and cannot only be found on this website but on all of STADA’s advertisements.


One of the Group’s strategic focuses is on the further expansion and internationalization of the Branded Products segment. STADA is present in more than 30 countries with about 50 sales companies. Branded Products such as Grippostad, Ladival, Covonia (UK) and Aqualor (Russia) are among the top sellers in their respective product category.


With their high level of expertise and their strong commitment, employees have played a key role in the longstanding successful development of the Group. STADA pursues a long-term oriented personnel management to secure this success factor and for the sustainable development of employees.


+44(0)1189 209 500
[email protected]
200 Longwater Ave, Green Park, Reading, Berkshire, RG2 6GP

Connect with us

© Copyright 2018 Britannia Pharmaceuticals

Job Code BRIT-0720-11423
Date of Preparation: August 2020

Britannia Pharmaceuticals Ltd, a company registered in England and Wales. Registered Office: 200 Longwater Avenue, Green Park, Reading, Berkshire RG2 6GP. Registered No. 01557088